Radiant Biotherapeutics

Quebec, Canada corporation · 2 known investors

Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.

BiotechMedical Devicesin /72035054

Founders & leadership

Arthur FratamicoExecutive Officer, Promoter

Deborah Geraghty, Ph.D.President and Chief Executive Officer

Investors · 2

FACIT (Fight Against Cancer Innovation Trust)Toronto · $1.1M

Toronto Innovation Acceleration PartnersToronto

Reported raises · per SEC filings

Form D private placements

▶$34.3MraisedOct 2024 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Arthur FratamicoExecutive Officer, Promoter

Offering amount: $34.3M
Amount sold: $34.3M
Minimum investment: $500K
First sale: Aug 2024
Incorporated: Corporation, Quebec, Canada, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.